Isodiol International Inc (ISOLF)
0.00
USD |
OTCM |
Apr 18, 16:00
Isodiol International Total Liabilities (Quarterly): 8.760M for Dec. 31, 2019
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 8.760M |
| September 30, 2019 | 10.61M |
| June 30, 2019 | 10.74M |
| March 31, 2019 | 12.50M |
| December 31, 2018 | 46.89M |
| September 30, 2018 | 48.95M |
| June 30, 2018 | 47.98M |
| March 31, 2018 | 5.187M |
| December 31, 2017 | 2.883M |
| June 30, 2017 | 6.489M |
| March 31, 2017 | 0.2814M |
| Date | Value |
|---|---|
| December 31, 2016 | 0.5953M |
| September 30, 2016 | 1.002M |
| June 30, 2016 | 0.8931M |
| March 31, 2016 | 0.9455M |
| December 31, 2015 | 0.7259M |
| September 30, 2015 | 0.48M |
| June 30, 2015 | 0.0188M |
| March 31, 2015 | 0.3282M |
| December 31, 2014 | 0.0022M |
| September 30, 2014 | 0.0095M |
| June 30, 2014 | 0.0041M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.760M
Minimum
Dec 2019
10.74M
Maximum
Jun 2019
10.03M
Average
10.61M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Liminal Biosciences Inc (DELISTED) | 7.790M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.443M |
| Shareholders Equity (Quarterly) | -0.3172M |